Clinical trial
Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis - a Randomized, Double Blind, Placebo Controlled Trial
NCT03086070 is registered in ClinicalTrials.gov with Children's Hospital Srebrnjak as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis - a Randomized, Double Blind, Placebo Controlled Trial
- Lead sponsor
- Children's Hospital Srebrnjak
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2010
- Completion date
- June 30, 2010
- Enrollment
- 60 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinosinusitis (diagnosis), laryngopharyngeal reflux